INFERTILITY DRUGS MARKET ANALYSIS

In order to treat infertility problems among the population there are many dugs present in the market such as Clomiphene (Clomid), Letrozole (Femara), Gonadotropins, etc. These drugs are used to trigger ovulation or to trigger hormones for proper functioning of ovaries. According to data published in 2018, in Shady Grove Fertility, Clomiphene is being prescribed by doctors for more than 50 years and still being extensively used to treat infertility cases in women. High blood sugar levels and Poly Cystic Ovarian Syndrome (PCOS) also interferes in sustaining pregnancy. To control the blood sugar and PCOS Metformin is highly prescribed drug. Metformin is sold under the brand name of Glucophage, Glumetza, Glucophage XR, and Fortamet.

Press Release

https://www.coherentmarketinsights.com/press-release/infertility-drugs-market-to-surpass-us-62-billion-by-2026-1413

Market Dynamics

Increasing prevalence of infertility in couples is highly contributing to infertility drugs market size. For instance, According to Centres for Disease Control and Prevention (CDC) report of 2018, about 6% of women aged 15 to 44 years in the U.S. were unable to get pregnant after one year of trying (infertility). Also, about 12% of women aged 15 to 44 years in the U.S. have difficulty getting pregnant or carrying a pregnancy to term. Infertility also affects rising number of men. According to the same source, almost 9% of men aged 25 to 44 years in the U.S. reported that they required medical help for reproduction.

The restraining factors for the infertility drug market growth is the potential risks of infertility drugs. Risks of infertility includes pregnancy with multiples, ovarian hyper-stimulation syndrome, long-term risks of ovarian tumours etc. According to the data published by Mayo Clinic Organisation in 2018, oral medications have less risk of multiples pregnancy (less than 10 percent) and mostly a risk of twins. And according to the same source, chances increase up to 30 percent with injectable medications. Injectable fertility medications also carry the major risk of triplets or more (higher order multiple pregnancy).

Request Sample

Download PDF

Key features of the study:

This report provides in-depth analysis of the infertility drugs market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global infertility drugs market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

Key players covered as a part of this study include Merck & Co., Ferring Pharmaceuticals, LIVZON Pharmaceutical Group Inc., Abbott Laboratories, Bayer AG, and Zydus Pharmaceuticals

Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global infertility drugs market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for infertility drugs market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Infertility Drugs Market, By Drug Type:

Clomiphene citrate
Sex hormones

Estrogen
Progesterone
Testosterone

Gonadotropins
Bromocriptine
Cabergoline
Imipramine
Letrozole
Metformin

Global Infertility Drugs Market, By Route of Administration:

Oral
Intravenous
Subcutaneous
Intramuscular

Global Infertility Drugs Market, By Gender:

Male
Female

Global Infertility Drugs Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Infertility Drugs Market, By Region:

North America

By Country:

U.S.
Canada

By Drug Type:

Clomiphene citrate
Sex Hormones

Estrogen
Progesterone
Testosterone

Gonadotropins
Bromocriptine
Cabergoline
Imipramine
Letrozole
Metformin

By Route of Administration:

Oral
Intravenous
Subcutaneous
Intramuscular

By Gender:

Male
Female

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Europe

By Country:

U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe

By Drug Type:

Clomiphene citrate
Sex Hormones

Estrogen
Progesterone
Testosterone

Gonadotropins
Bromocriptine
Cabergoline
Imipramine
Letrozole
Metformin

By Route of Administration:

Oral
Intravenous
Subcutaneous
Intramuscular

By Gender:

Male
Female

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Asia Pacific

By Country:

Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific

By Drug Type:

Clomiphene citrate
Sex Hormones

Estrogen
Progesterone
Testosterone

Gonadotropins
Bromocriptine
Cabergoline
Imipramine
Letrozole
Metformin

By Route of Administration:

Oral
Intravenous
Subcutaneous
Intramuscular

By Gender:

Male
Female

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Latin America

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

By Drug Type:

Clomiphene citrate
Sex Hormones

Estrogen
Progesterone
Testosterone

Gonadotropins
Bromocriptine
Cabergoline
Imipramine
Letrozole
Metformin

By Route of Administration:

Oral
Intravenous
Subcutaneous
Intramuscular

By Gender:

Male
Female

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Middle East

By Country:

GCC
Israel
Rest of Middle East

By Drug Type:

Clomiphene citrate
Sex Hormones

Estrogen
Progesterone
Testosterone

Gonadotropins
Bromocriptine
Cabergoline
Imipramine
Letrozole
Metformin

By Route of Administration:

Oral
Intravenous
Subcutaneous
Intramuscular

By Gender:

Male
Female

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Africa

By Country:

South Africa
Central Africa
North Africa

By Drug Type:

Clomiphene citrate
Sex Hormones

Estrogen
Progesterone
Testosterone

Gonadotropins
Bromocriptine
Cabergoline
Imipramine
Letrozole
Metformin

By Route of Administration:

Oral
Intravenous
Subcutaneous
Intramuscular

By Gender:

Male
Female

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Company Profiles

Merck & Co.*

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

Ferring Pharmaceuticals
LIVZON Pharmaceutical Group Inc.
Abbott Laboratories
Bayer AG
Zydus Pharmaceuticals

“*” marked represents similar

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

What we provide:

Customized Market Research Services
Industry Analysis Services
Business Consulting Services
Market Intelligence Services
Long term Engagement Model
Country Specific Analysis

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: [email protected]